rare disease

The German company reported its quarterly earnings for the first time as a public company, following the completion of its IPO on Nov. 7.

BTIG gave Centogene a Buy rating, while SVB Leerink and Evercore ISI each gave the company an Outperform rating. 

PTC Therapeutics is developing a gene therapy for the rare genetic disease AADC deficiency, which impacts the production of two key neurotransmitters.

Centogene's data repository includes rare disease patient data including clinical information, health records, and a range of -omics data.

The German company offers rare disease genetic tests and services for clinical applications, as well as to support drug discovery and development programs.

The Genomics Research and Innovation Network has built an open-source system for querying genotype-phenotype databases at its member hospitals.

The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.

The German company offers rare disease genetic tests and services for clinical applications and to support clients' drug discovery and development programs.